Zydus Life
A global lifesciences company driven by the purpose of delivering care and nurturance for the patients, backed by the power of innovation, science and cutting edge technology. With these attributes close to our heart, we wish to make a meaningful difference in …
About Zydus Group - The Leading Indian Pharma Company
Driven by creativity and innovation, we strive for excellence and to make a difference in the world of pharmaceuticals and healthcare. Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited), a leading Indian Pharmaceutical company is a fully integrated, global healthcare provider.
Zydus Lifesciences - Wikipedia
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, [3] is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs. [4] [5] [6] The company ranked 100th in the Fortune India 500 list in 2020. [7]
Zydus Pharmaceuticals
Zydus Lifesciences is a global, fully integrated pharmaceutical company with a presence in 50 countries and is committed to growing its presence around the world and in the United States. Zydus products were developed to save and improve patients’ lives.
Innovation from India to empower people to lead healthier ...
16 hours ago · Zydus Lifesciences Chairman Pankaj R Patel has been awarded the prestigious Padma Bhushan for his contributions to the lifesciences industry. Patel's innovations aim to provide affordable healthcare and empower people worldwide. His work involves transformative advancements in health and technology, and his leadership extends across various charitable …
Zydus Life up 2% on USFDA nod for Phase II(b) clinical trial ...
6 days ago · Zydus Lifesciences Q2 result: Net profit rises 13.8% to Rs 911.2 crore WHO approves Zydus Lifesciences' typhoid vaccine for UN procurement The Phase 2(b), randomized, double-blind, placebo-controlled, parallel-group, multicentre study will evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of Usnoflast administered to adult ...
FDA approves Zydus’ Phase IIb trial of Usnoflast for ALS ...
6 days ago · Zydus Lifesciences chairman Pankaj Patel said: “We are excited to report the approval from the USFDA to initiate this randomised, double-blind, placebo-controlled Phase IIb clinical trial in ALS ...